SEARCH

SEARCH BY CITATION

References

  • Akatsuka, Y., Morishima, Y., Kuzushima, K., Kodera, Y. & Takahashi, T. (2007) Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Science, 98, 11391146.
  • Appelbaum, F.R. (2001) Haematopoietic cell transplantation as immunotherapy. Nature, 411, 385389.
  • Bleakley, M. & Riddell, S.R. (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Reviews Cancer, 4, 371380.
  • Cemerski, S. & Shaw, A. (2006) Immune synapses in T-cell activation. Current Opinion in Immunology, 18, 298304.
  • Faroudi, M., Utzny, C., Salio, M., Cerundolo, V., Guiraud, M., Muller, S. & Valitutti, S. (2003) Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proceedings of the National Academy of Sciences of the United States of America, 100, 1414514150.
  • Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunology Reviews, 157, 125140.
  • Hambach, L. & Goulmy, E. (2005) Immunotherapy of cancer through targeting of minor histocompatibility antigens. Current Opinion in Immunology, 17, 202210.
  • Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555562.
  • Jedema, I., Van Der Werff, N.M., Barge, R.M., Willemze, R. & Falkenburg, J.H. (2004) New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood, 103, 26772682.
  • Marijt, W.A., Heemskerk, M.H., Kloosterboer, F.M., Goulmy, E., Kester, M.G., Van Der Hoorn, M.A., Luxemburg-Heys, S.A., Hoogeboom, M., Mutis, T., Drijfhout, J.W., Van Rood, J.J., Willemze, R. & Falkenburg, J.H. (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proceedings of the National Academy of Sciences of the United States of America, 100, 27422747.
  • Marsh, S.G.E., Parham, P. & Barber, L.D. (2000) The HLA Facts Book. Academic Press, London. p152.
  • Martin, P.J. (1997) How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation? Bone Marrow Transplantation, 20, 97100.
  • Riddell, S.R., Berger, C., Murata, M., Randolph, S. & Warren, E.H. (2003) The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Reviews, 17, 153162.
  • De Rijke, B., Horssen-Zoetbrood, A., Beekman, J.M., Otterud, B., Maas, F., Woestenenk, R., Kester, M., Leppert, M., Schattenberg, A.V., De Witte, T., Van De Wiel-van Kemenade, E. & Dolstra, H. (2005) A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. Journal of Clinical Investigation, 115, 35063516.
  • Spierings, E., Wieles, B. & Goulmy, E. (2004) Minor histocompatibility antigens--big in tumour therapy. Trends in Immunology, 25, 5660.
  • Valitutti, S., Muller, S., Dessing, M. & Lanzavecchia, A. (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. Journal of Experimental Medicine, 183, 19171921.
  • Warren, E.H., Gavin, M., Greenberg, P.D. & Riddell, S.R. (1998) Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Current Opinion in Hematology, 5, 429433.
  • Wiedemann, A., Depoil, D., Faroudi, M. & Valitutti, S. (2006) Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proceedings of the National Academy of Sciences of the United States of America, 103, 1098510990.